News

Mission

The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

FoxO6-mediated ApoC3 Upregulation Promotes Hepatic Steatosis and Hyperlipidemia in HFD Aged Rats

Aging

March 20, 2024

PRESS RELEASE: On March 3, 2024, a new research paper was published in Aging's Volume 16, Issue 5, entitled, “FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet.” continue reading »

Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®

News

March 20, 2024

PRESS RELEASE: On March 14, 2024, a new research paper was published in Oncotarget, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.” continue reading »

PR55α-controlled PP2A Inhibits p16 Expression and Blocks Cellular Senescence Induction

Aging

March 19, 2024

PRESS RELEASE: On March 4, 2024, a new research paper was published in Aging's Volume 16, Issue 5, entitled, “PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.” continue reading »

“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny

News

March 19, 2024

PRESS RELEASE: On March 15, 2024, a new research perspective was published by Mikhail V. Blagosklonny M.D., Ph.D., in Oncotarget, entitled, “From osimertinib to preemptive combinations.” continue reading »

A New Antibody Capture Method Reveals G-quadruplex Landscape and its Regulation

News

March 18, 2024

PRESS RELEASE: On March 14, 2024, a new research paper was published in Oncotarget, entitled, “G-quadruplex landscape and its regulation revealed by a new antibody capture method.” continue reading »

« Previous 1 … 29 30 31 32 33 … 102 Next »